FNIP2
Folliculin-interacting protein 2
Also known as: FNIP2_HUMAN, FNIPL, KIAA1450, MAPO1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P278
- Gene
- FNIP2
- Ensembl
- ENSG00000052795
- Chromosome
- 4
- Canonical length
- 1114 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Centriolar satellite,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that binds to the tumor suppressor folliculin and to AMP-activated protein kinase (AMPK), and may play a role cellular metabolism and nutrient sensing by regulating the AMPK-mechanistic target of rapamycin signaling pathway. The encoded protein may also be involved in regulating the O6-methylguanine-induced apoptosis signaling pathway. This gene has a closely related paralog that encodes a protein with similar binding activities. Both related proteins also associate with the molecular chaperone heat shock protein-90 (Hsp90) and negatively regulate its ATPase activity and facilitate its association with folliculin. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
1114 residues, UniProt reviewed canonical sequence.
>Q9P278|FNIP2
1 MAPTLLQKLF NKRGSSGSSA AASAQGRAPK EGPAFSWSCS EFDLNEIRLI VYQDCDRRGR
61 QVLFDSKAVQ KIEEVTAQKT EDVPIKISAK CCQGSSSVSS SSSSSISSHS SSGGSSHHAK
121 EQLPKYQYTR PASDVNMLGE MMFGSVAMSY KGSTLKIHYI RSPPQLMISK VFSARMGSFC
181 GSTNNLQDSF EYINQDPNLG KLNTNQNSLG PCRTGSNLAH STPVDMPSRG QNEDRDSGIA
241 RSASLSSLLI TPFPSPSSST SSSSSYQRRW LRSQTTSLEN GIIPRRSTDE TFSLAEETCS
301 SNPAMVRRKK IAISIIFSLC EKEEAQRNFQ DFFFSHFPLF ESHMNRLKSA IEKAMISCRK
361 IAESSLRVQF YVSRLMEALG EFRGTIWNLY SVPRIAEPVW LTMMSGTLEK NQLCQRFLKE
421 FTLLIEQINK NQFFAALLTA VLTYHLAWVP TVMPVDHPPI KAFSEKRTSQ SVNMLAKTHP
481 YNPLWAQLGD LYGAIGSPVR LTRTVVVGKQ KDLVQRILYV LTYFLRCSEL QENQLTWSGN
541 HGEGDQVLNG SKIITALEKG EVEESEYVVI TVRNEPALVP PILPPTAAER HNPWPTGFPE
601 CPEGTDSRDL GLKPDKEANR RPEQGSEACS AGCLGPASDA SWKPQNAFCG DEKNKEAPQD
661 GSSRLPSCEV LGAGMKMDQQ AVCELLKVEM PTRLPDRSVA WPCPDRHLRE KPSLEKVTFQ
721 IGSFASPESD FESRMKKMEE RVKACGPSLE ASEAADVAQD PQVSRSPFKP GFQENVCCPQ
781 NRLSEGDEGE SDKGFAEDRG SRNDMAADIA GQLSHAADLG TASHGAGGTG GRRLEATRGL
841 YVKAAEGPVL EPVAPRCVQR GPGLVAGANI PCGDDNKKAN FRTEGDIPRN ESSDSALGDS
901 DDEACASAML DLGHGGDRTG GSLEVELPLP RSQSISTQNV RNFGRSLLAG YCPTYMPDLV
961 LHGTGSDEKL KQCLVADLVH TVHHPVLDEP IAEAVCIIAD TDKWSVQVAT SQRKVTDNMK
1021 LGQDVLVSSQ VSSLLQSILQ LYKLHLPADF CIMHLEDRLQ EMYLKSKMLS EYLRGHTRVH
1081 VKELGVVLGI ESNDLPLLTA IASTHSPYVA QILLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FNIP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- liver: 55 nTPM
- kidney: 45 nTPM
- placenta: 28 nTPM
- adipose tissue: 25 nTPM
- heart muscle: 24 nTPM
- lung: 24 nTPM
Single-cell type
- monocytes: 610 nCPM
- macrophages: 531 nCPM
- cdc: 453 nCPM
- renal collecting duct intercalated cells: 427 nCPM
- endometrial glandular cells: 425 nCPM
- proximal tubule cells: 396 nCPM
Immune cell
- non-classical monocyte: 7.2 nTPM
- intermediate monocyte: 3.3 nTPM
- myeloid DC: 2.1 nTPM
- classical monocyte: 0.7 nTPM
- naive CD8 T-cell: 0.6 nTPM
- NK-cell: 0.6 nTPM
Brain region
- thalamus: 63 nTPM
- white matter: 50 nTPM
- basal ganglia: 40 nTPM
- hippocampal formation: 39 nTPM
- cerebral cortex: 35 nTPM
- medulla oblongata: 35 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.28
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intrinsic apoptotic signaling pathway in response to DNA damage
- negative regulation of transcription by RNA polymerase II
- positive regulation of protein-containing complex assembly
- positive regulation of TORC1 signaling
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Folliculin-interacting protein family
- Folliculin-interacting protein, N-terminal domain
- Folliculin-interacting protein, middle domain
- Folliculin-interacting protein, C-terminal domain
- Tripartite DENN domain, FNIP1/2-type
- Folliculin-interacting protein N-terminus
- Folliculin-interacting protein middle domain
- Folliculin-interacting protein C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FNIP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FNIP2 as an antibody target. Whether an autoantibody or antibody against FNIP2 could matter depends on whether native FNIP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FNIP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FNIP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...